Epidarex Capital, a transatlantic life science venture firm, has acquired Sirakoss by OssDsign, a Swedish medtech company, for an initial cash consideration of $11 million plus milestone and royalty payments. Share this:TwitterFacebookLike this:Like Loading... You May Also Like Healthcare Technology 28-10-2022 MEDITECH Continues Push into Ambulatory EHR Market Healthcare Technology 29-01-2021 HMP Wandsworth uses referral software to keep inmates out of hospital Healthcare Technology 23-11-2020 Packaging firm expands portfolio to include face masks Healthcare Technology 30-07-2021 Even providers with robust cybersecurity programs are struggling to secure their supply chain systems